South Africa expands HIV prevention jab access to at-risk groups
South Africa expands HIV prevention jab access to at-risk groups, offering long-acting lenacapir protection for up to six months.
Category
South Africa expands HIV prevention jab access to at-risk groups, offering long-acting lenacapir protection for up to six months.